RYAN SPECIALTY HOLDINGS INC (RYAN) Fundamental Analysis & Valuation

NYSE:RYAN • US78351F1075

Current stock price

38.25 USD
+0.36 (+0.95%)
At close:
38.25 USD
0 (0%)
After Hours:

This RYAN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. RYAN Profitability Analysis

1.1 Basic Checks

  • RYAN had positive earnings in the past year.
  • RYAN had a positive operating cash flow in the past year.
  • Each year in the past 5 years RYAN has been profitable.
  • In the past 5 years RYAN always reported a positive cash flow from operatings.
RYAN Yearly Net Income VS EBIT VS OCF VS FCFRYAN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

1.2 Ratios

  • The Return On Assets of RYAN (0.60%) is worse than 68.71% of its industry peers.
  • RYAN has a Return On Equity of 9.78%. This is comparable to the rest of the industry: RYAN outperforms 44.22% of its industry peers.
  • RYAN has a better Return On Invested Capital (8.96%) than 89.12% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for RYAN is in line with the industry average of 9.51%.
Industry RankSector Rank
ROA 0.6%
ROE 9.78%
ROIC 8.96%
ROA(3y)0.81%
ROA(5y)0.92%
ROE(3y)11.92%
ROE(5y)13.57%
ROIC(3y)9.61%
ROIC(5y)9.36%
RYAN Yearly ROA, ROE, ROICRYAN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

1.3 Margins

  • RYAN has a worse Profit Margin (2.08%) than 80.95% of its industry peers.
  • In the last couple of years the Profit Margin of RYAN has declined.
  • Looking at the Operating Margin, with a value of 20.06%, RYAN is in the better half of the industry, outperforming 74.15% of the companies in the same industry.
  • In the last couple of years the Operating Margin of RYAN has grown nicely.
Industry RankSector Rank
OM 20.06%
PM (TTM) 2.08%
GM N/A
OM growth 3Y-2.85%
OM growth 5Y5.21%
PM growth 3Y-16.65%
PM growth 5Y-20.85%
GM growth 3YN/A
GM growth 5YN/A
RYAN Yearly Profit, Operating, Gross MarginsRYAN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

3

2. RYAN Health Analysis

2.1 Basic Checks

  • RYAN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • RYAN has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for RYAN has been increased compared to 5 years ago.
  • The debt/assets ratio for RYAN has been reduced compared to a year ago.
RYAN Yearly Shares OutstandingRYAN Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
RYAN Yearly Total Debt VS Total AssetsRYAN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.2 Solvency

  • Based on the Altman-Z score of 1.08, we must say that RYAN is in the distress zone and has some risk of bankruptcy.
  • RYAN has a Altman-Z score of 1.08. This is amongst the best in the industry. RYAN outperforms 80.27% of its industry peers.
  • The Debt to FCF ratio of RYAN is 5.85, which is a neutral value as it means it would take RYAN, 5.85 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 5.85, RYAN is doing worse than 68.03% of the companies in the same industry.
  • RYAN has a Debt/Equity ratio of 5.08. This is a high value indicating a heavy dependency on external financing.
  • RYAN has a Debt to Equity ratio of 5.08. This is amonst the worse of the industry: RYAN underperforms 93.88% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.08
Debt/FCF 5.85
Altman-Z 1.08
ROIC/WACC1.14
WACC7.85%
RYAN Yearly LT Debt VS Equity VS FCFRYAN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

2.3 Liquidity

  • RYAN has a Current Ratio of 0.98. This is a bad value and indicates that RYAN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 0.98, RYAN is in the better half of the industry, outperforming 78.91% of the companies in the same industry.
  • RYAN has a Quick Ratio of 0.98. This is a bad value and indicates that RYAN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of RYAN (0.98) is better than 78.91% of its industry peers.
Industry RankSector Rank
Current Ratio 0.98
Quick Ratio 0.98
RYAN Yearly Current Assets VS Current LiabilitesRYAN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

6

3. RYAN Growth Analysis

3.1 Past

  • RYAN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.06%, which is quite good.
  • Measured over the past years, RYAN shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -20.00% on average per year.
  • The Revenue has decreased by -0.54% in the past year.
  • Measured over the past years, RYAN shows a very strong growth in Revenue. The Revenue has been growing by 24.54% on average per year.
EPS 1Y (TTM)10.06%
EPS 3Y19.65%
EPS 5Y-20%
EPS Q2Q%0%
Revenue 1Y (TTM)-0.54%
Revenue growth 3Y20.93%
Revenue growth 5Y24.54%
Sales Q2Q%13.21%

3.2 Future

  • The Earnings Per Share is expected to grow by 17.47% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 14.67% on average over the next years. This is quite good.
EPS Next Y17.41%
EPS Next 2Y16.87%
EPS Next 3Y16.55%
EPS Next 5Y17.47%
Revenue Next Year10.45%
Revenue Next 2Y11.46%
Revenue Next 3Y11.79%
Revenue Next 5Y14.67%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
RYAN Yearly Revenue VS EstimatesRYAN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B 4B 5B
RYAN Yearly EPS VS EstimatesRYAN Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1 2 3 4

2

4. RYAN Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 19.42 indicates a rather expensive valuation of RYAN.
  • 76.19% of the companies in the same industry are cheaper than RYAN, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 27.71. RYAN is valued slightly cheaper when compared to this.
  • A Price/Forward Earnings ratio of 16.54 indicates a correct valuation of RYAN.
  • Based on the Price/Forward Earnings ratio, RYAN is valued a bit more expensive than 66.67% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 38.09. RYAN is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 19.42
Fwd PE 16.54
RYAN Price Earnings VS Forward Price EarningsRYAN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 60.54% of the companies in the same industry are cheaper than RYAN, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, RYAN is valued a bit more expensive than the industry average as 65.31% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 17.58
EV/EBITDA 14.63
RYAN Per share dataRYAN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 -10 -15

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • RYAN's earnings are expected to grow with 16.55% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.12
PEG (5Y)N/A
EPS Next 2Y16.87%
EPS Next 3Y16.55%

1

5. RYAN Dividend Analysis

5.1 Amount

  • RYAN has a Yearly Dividend Yield of 1.31%.
  • The stock price of RYAN dropped by -23.50% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
  • RYAN's Dividend Yield is comparable with the industry average which is at 2.37.
  • Compared to the average S&P500 Dividend Yield of 1.81, RYAN is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.31%

5.2 History

  • RYAN has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
RYAN Yearly Dividends per shareRYAN Yearly Dividends per shareYearly Dividends per share 2024 2025 2026 0.2 0.4 0.6

5.3 Sustainability

  • RYAN pays out 98.33% of its income as dividend. This is not a sustainable payout ratio.
DP98.33%
EPS Next 2Y16.87%
EPS Next 3Y16.55%
RYAN Yearly Income VS Free CF VS DividendRYAN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 2025 0 200M 400M
RYAN Dividend Payout.RYAN Dividend Payout, showing the Payout Ratio.RYAN Dividend Payout.PayoutRetained Earnings

RYAN Fundamentals: All Metrics, Ratios and Statistics

RYAN SPECIALTY HOLDINGS INC

NYSE:RYAN (4/21/2026, 8:11:27 PM)

After market: 38.25 0 (0%)

38.25

+0.36 (+0.95%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)02-12
Earnings (Next)04-30
Inst Owners87.09%
Inst Owner Change-0.21%
Ins Owners13.74%
Ins Owner Change0.58%
Market Cap10.07B
Revenue(TTM)3.05B
Net Income(TTM)63.40M
Analysts77.6
Price Target52.38 (36.94%)
Short Float %8.75%
Short Ratio4.18
Dividend
Industry RankSector Rank
Dividend Yield 1.31%
Yearly Dividend0.24
Dividend Growth(5Y)N/A
DP98.33%
Div Incr Years0
Div Non Decr Years0
Ex-Date02-24
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-6.32%
Min EPS beat(2)-11.31%
Max EPS beat(2)-1.33%
EPS beat(4)0
Avg EPS beat(4)-3.88%
Min EPS beat(4)-11.31%
Max EPS beat(4)-0.61%
EPS beat(8)1
Avg EPS beat(8)-2.68%
EPS beat(12)3
Avg EPS beat(12)-1.54%
EPS beat(16)6
Avg EPS beat(16)-0.42%
Revenue beat(2)1
Avg Revenue beat(2)-2.47%
Min Revenue beat(2)-5.29%
Max Revenue beat(2)0.35%
Revenue beat(4)2
Avg Revenue beat(4)-1.21%
Min Revenue beat(4)-5.29%
Max Revenue beat(4)0.66%
Revenue beat(8)2
Avg Revenue beat(8)-1.31%
Revenue beat(12)3
Avg Revenue beat(12)-0.82%
Revenue beat(16)5
Avg Revenue beat(16)-0.48%
PT rev (1m)-10.2%
PT rev (3m)-21.15%
EPS NQ rev (1m)-3.41%
EPS NQ rev (3m)-6.5%
EPS NY rev (1m)-1.41%
EPS NY rev (3m)-5.77%
Revenue NQ rev (1m)-1.19%
Revenue NQ rev (3m)-2.72%
Revenue NY rev (1m)-1.56%
Revenue NY rev (3m)-5.22%
Valuation
Industry RankSector Rank
PE 19.42
Fwd PE 16.54
P/S 3.3
P/FCF 17.58
P/OCF 15.64
P/B 15.53
P/tB N/A
EV/EBITDA 14.63
EPS(TTM)1.97
EY5.15%
EPS(NY)2.31
Fwd EY6.05%
FCF(TTM)2.18
FCFY5.69%
OCF(TTM)2.45
OCFY6.39%
SpS11.59
BVpS2.46
TBVpS-15.93
PEG (NY)1.12
PEG (5Y)N/A
Graham Number10.4474 (-72.69%)
Profitability
Industry RankSector Rank
ROA 0.6%
ROE 9.78%
ROCE 11.39%
ROIC 8.96%
ROICexc 9.23%
ROICexgc 128.26%
OM 20.06%
PM (TTM) 2.08%
GM N/A
FCFM 18.77%
ROA(3y)0.81%
ROA(5y)0.92%
ROE(3y)11.92%
ROE(5y)13.57%
ROIC(3y)9.61%
ROIC(5y)9.36%
ROICexc(3y)11.17%
ROICexc(5y)11.42%
ROICexgc(3y)109.28%
ROICexgc(5y)95.22%
ROCE(3y)12.21%
ROCE(5y)11.9%
ROICexgc growth 3Y25.26%
ROICexgc growth 5YN/A
ROICexc growth 3Y-11.15%
ROICexc growth 5Y5.12%
OM growth 3Y-2.85%
OM growth 5Y5.21%
PM growth 3Y-16.65%
PM growth 5Y-20.85%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 5.08
Debt/FCF 5.85
Debt/EBITDA 3.66
Cap/Depr 24.68%
Cap/Sales 2.33%
Interest Coverage 3.12
Cash Conversion 71.55%
Profit Quality 903.33%
Current Ratio 0.98
Quick Ratio 0.98
Altman-Z 1.08
F-Score4
WACC7.85%
ROIC/WACC1.14
Cap/Depr(3y)26.14%
Cap/Depr(5y)82.48%
Cap/Sales(3y)1.88%
Cap/Sales(5y)6.32%
Profit Quality(3y)710.24%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.06%
EPS 3Y19.65%
EPS 5Y-20%
EPS Q2Q%0%
EPS Next Y17.41%
EPS Next 2Y16.87%
EPS Next 3Y16.55%
EPS Next 5Y17.47%
Revenue 1Y (TTM)-0.54%
Revenue growth 3Y20.93%
Revenue growth 5Y24.54%
Sales Q2Q%13.21%
Revenue Next Year10.45%
Revenue Next 2Y11.46%
Revenue Next 3Y11.79%
Revenue Next 5Y14.67%
EBIT growth 1Y-15.63%
EBIT growth 3Y17.48%
EBIT growth 5Y31.03%
EBIT Next Year65.96%
EBIT Next 3Y29.95%
EBIT Next 5Y29.95%
FCF growth 1Y22.41%
FCF growth 3Y22.35%
FCF growth 5Y37.22%
OCF growth 1Y25.02%
OCF growth 3Y24.26%
OCF growth 5Y36.59%

RYAN SPECIALTY HOLDINGS INC / RYAN Fundamental Analysis FAQ

What is the fundamental rating for RYAN stock?

ChartMill assigns a fundamental rating of 4 / 10 to RYAN.


What is the valuation status for RYAN stock?

ChartMill assigns a valuation rating of 2 / 10 to RYAN SPECIALTY HOLDINGS INC (RYAN). This can be considered as Overvalued.


What is the profitability of RYAN stock?

RYAN SPECIALTY HOLDINGS INC (RYAN) has a profitability rating of 4 / 10.


What is the valuation of RYAN SPECIALTY HOLDINGS INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for RYAN SPECIALTY HOLDINGS INC (RYAN) is 19.42 and the Price/Book (PB) ratio is 15.53.


What is the expected EPS growth for RYAN SPECIALTY HOLDINGS INC (RYAN) stock?

The Earnings per Share (EPS) of RYAN SPECIALTY HOLDINGS INC (RYAN) is expected to grow by 17.41% in the next year.